A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Part of paid clinical trials in Berkeley, California.

Sponsor
Glaxo Wellcome
Study ID
NCT00005663
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to see if valacyclovir (Valtrex) is a safe and effective treatment for ano-genital HSV infections (herpes simplex virus infections of the anus and external genitals) in HIV-infected patients.

Key Dates

First listed
Aug 31, 2001
Start date
Jun 30, 1999
Status verified
Jul 2001

Study Design

Primary purpose
TREATMENT

Locations (20)

FacilityCityStateZIPSite coordinators
East Bay AIDS CtrBerkeleyCalifornia94705-
Pacific Oaks ResearchBeverly HillsCalifornia90211-
Kraus Med PartnersLos AngelesCalifornia90036-
ViRx IncSan FranciscoCalifornia94109-
IDC Research InitiativeAltamonte SpringsFlorida32701-
Healthnet InstituteFort LauderdaleFlorida33316-
Univ of Miami School of MedicineMiamiFlorida331361013-
Treasure Coast Infectious Disease ConsultantsVero BeachFlorida32960-
Palm Beach Research CtrWest Palm BeachFlorida33409-
Indiana Univ School of Medicine / Dept of Infect DisIndianapolisIndiana46202-
Univ of MinnesotaMinneapolisMinnesota55455-
Advanced Biomedical Research IncHackensackNew Jersey07601-
Nalle Clinic / Clinical Research DeptCharlotteNorth Carolina28207-
Wake County Dept of HealthRaleighNorth Carolina27610-
Westover Heights ClinicPortlandOregon97210-
Philadelphia FIGHTPhiladelphiaPennsylvania19107-
Dr Alvan FisherProvidenceRhode Island02907-
Baylor College of Medicine / Dept of MedicineHoustonTexas770303498-
Richmond AIDS ConsortiumRichmondVirginia23219-
Univ of Washington Virology Research ClinicSeattleWashington98122-

Find similar trials in Berkeley, CA

By condition
By specialty

Related Studies